Time-Dependent Gene Profiling Indicates the Presence of Different Phases for Ischemia/Reperfusion Injury in Retina
Author(s) -
Kalina Andreeva,
Meixia Zhang,
Wei Fan,
Xiaohong Li,
Yinlu Chen,
Jovan David Rebolledo-Mendez,
Nigel G. F. Cooper
Publication year - 2014
Publication title -
ophthalmology and eye diseases
Language(s) - English
Resource type - Journals
ISSN - 1179-1721
DOI - 10.4137/oed.s17671
Subject(s) - reperfusion injury , ischemia , gene , signal transduction , inflammation , biology , retina , gene expression , complement system , gene expression profiling , immune system , medicine , pathology , bioinformatics , immunology , neuroscience , microbiology and biotechnology , genetics
Ischemia/reperfusion (IR) injury has been associated with several retinal pathologies, and a few genes/gene products have been linked to IR injury. However, the big picture of temporal changes, regarding the affected gene networks, pathways, and processes remains to be determined. The purpose of the present study was to investigate initial, intermediate, and later stages to characterize the etiology of IR injury in terms of the pathways affected over time. Analyses indicated that at the initial stage, 0-hour reperfusion following the ischemic period, the ischemia-associated genes were related to changes in metabolism. In contrast, at the 24-hour time point, the signature events in reperfusion injury include enhanced inflammatory and immune responses as well as cell death indicating that this would be a critical period for the development of any interventional therapeutic strategies. Genes in the signal transduction pathways, particularly transmitter receptors, are downregulated at this time. Activation of the complement system pathway clearly plays an important role in the later stages of reperfusion injury. Together, these results demonstrate that the etiology of injury related to IR is characterized by the appearance of specific patterns of gene expression at any given time point during retinal IR injury. These results indicate that evaluation of treatment strategies with respect to time is very critical.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom